Dmitry Gabrilovich

Dmitry Gabrilovich

Known for	Research on Myeloid-derived suppressor cells

Dmitry Gabrilovich is a prominent scientist known for his pioneering work in the field of immunology and cancer research. He is particularly recognized for his research on myeloid-derived suppressor cells (MDSCs), which play a crucial role in the tumor microenvironment and immune evasion by cancer cells.

Education and Career

Dmitry Gabrilovich received his education in medicine and biomedical research, focusing on the mechanisms of immune suppression in cancer. He has held various academic and research positions, contributing significantly to the understanding of how tumors evade the immune system.

Currently, he is affiliated with the Wistar Institute, where he leads a research team dedicated to exploring the interactions between the immune system and cancer. His work has been instrumental in developing new strategies for cancer immunotherapy.

Research Contributions

Gabrilovich's research has shed light on the role of myeloid-derived suppressor cells in cancer progression. These cells are known to accumulate in cancer patients and suppress T cell responses, thereby facilitating tumor growth and metastasis.

His studies have demonstrated that targeting MDSCs can enhance the efficacy of immunotherapeutic approaches, making them a promising target for cancer treatment.

Publications and Awards

Dmitry Gabrilovich has published numerous articles in prestigious scientific journals, contributing to the body of knowledge in immunology and oncology. His work has been recognized with several awards, highlighting his impact on the field of cancer research.

See Also

• Immunotherapy
• Tumor microenvironment
• Cancer immunology

References

<references />

External Links

• [Wistar Institute Profile](https://www.wistar.org/our-scientists/dmitry-gabrilovich)